For citations:
Fedyanin M.Yu., Vladimirova L.Yu., Chubenko V.A., Zagorskaya L.A., Belyayeva A.V., Bolotina L.V., Moiseyenko F.V., Fakhrutdinova O.L., Belukhin S.A., Zhabina A.S., Khalikova L.V., Moiseyenko V.M., Meshcheryakov A.A., Artamonova E.V., Pokatayev I.A., Khasanova A.I., Belonogov A.V., Musayeva Kh.S., Novikova O.Yu., Stradayeva I.Yu., Popova I.L., Mukhametshina G.Z., Orlova R.V., Erdniev S.P., Ivanova A.K., Androsova A.V., Feoktistova P.S., Kuzmina Ye.S., Karabina Ye.V., Nekrasova O.V., Sherstnev V.M., Mishchenko A.A., Mukova L.A., Kertiev B.Kh., Kosar G.I., Osodoyeva S.N., Katz A.I., Malina R.R., Tryakin A.A., Tyulyandin S.A. Toxicity and efficacy of FOLFIRI regimen and aflibercept combination in metastatic colorectal cancer: first results of a Russian multicenter retrospective study. Malignant tumours. 2019;9(2):53-63. (In Russ.) https://doi.org/10.18027/2224-5057-0-0-0-
Email this article 